Loretta Nastoupil, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Drug Development B cell lymphoma
    Date added:
    01/22/2025
    Date updated:
    01/22/2025
    Relationship end date:
    12/07/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Regeneron
    Topic:
    Drug Development B cell lymphoma
    Date added:
    01/22/2025
    Date updated:
    01/22/2025
    Relationship end date:
    07/01/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Takeda
    Topic:
    Drug Development B cell lymphoma
    Date added:
    01/22/2025
    Date updated:
    01/22/2025
    Relationship end date:
    07/01/2024

Pages

Return to 14th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego